Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.86
(
0.62%
)
US TECH 100
29,075.20
(
1.30%
)
Dow Jones
50,734.10
(
0.31%
)
Brent Oil
96.31
(
-4.81%
)
Bitcoin
77,122.10
(
-0.19%
)
News Focus
News Focus
Post# of 257628
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123010
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 141152

Wednesday, 05/02/2012 10:10:21 AM

Wednesday, May 02, 2012 10:10:21 AM

Post# of 257628

PLX…are planning to enter the clinic with PRX-106 (anti-TNF fusion protein) later this year, despite of Amgen's new patent related to Enbrel.

What is the strategy to work around the AMGN patent, IYO?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today